celecoxib has been researched along with Medulloblastoma in 6 studies
Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)
Excerpt | Relevance | Reference |
---|---|---|
"Neutropenia was the main side effect of the metronomic therapy." | 5.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
"Neutropenia was the main side effect of the metronomic therapy." | 1.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
"Medulloblastomas are the most common malignant brain tumors in children." | 1.37 | Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. ( Baryawno, N; Darabi, A; FuskevÅg, OM; Johnsen, JI; Khan, Z; Kogner, P; Nordenskjöld, M; Odeberg, J; Rahbar, A; Segerström, L; Siesjö, P; Söderberg-Nauclér, C; Sveinbjörnsson, B; Taher, C; Wolmer-Solberg, N, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hauser, P | 1 |
Vancsó, I | 1 |
Pócza, T | 1 |
Schuler, D | 1 |
Garami, M | 1 |
Yang, MY | 1 |
Lee, HT | 1 |
Chen, CM | 1 |
Shen, CC | 1 |
Ma, HI | 1 |
Wickström, M | 1 |
Dyberg, C | 1 |
Milosevic, J | 1 |
Einvik, C | 1 |
Calero, R | 1 |
Sveinbjörnsson, B | 2 |
Sandén, E | 1 |
Darabi, A | 2 |
Siesjö, P | 2 |
Kool, M | 1 |
Kogner, P | 2 |
Baryawno, N | 2 |
Johnsen, JI | 2 |
Chen, KH | 1 |
Hsu, CC | 1 |
Song, WS | 1 |
Huang, CS | 1 |
Tsai, CC | 1 |
Kuo, CD | 1 |
Hsu, HS | 1 |
Tsai, TH | 1 |
Tsai, CY | 1 |
Woung, LC | 1 |
Chiou, SH | 1 |
Lu, KH | 1 |
Chen, YW | 1 |
Rahbar, A | 1 |
Wolmer-Solberg, N | 1 |
Taher, C | 1 |
Odeberg, J | 1 |
Khan, Z | 1 |
FuskevÅg, OM | 1 |
Segerström, L | 1 |
Nordenskjöld, M | 1 |
Söderberg-Nauclér, C | 1 |
Nygaard, R | 1 |
Kivivuori, SM | 1 |
6 other studies available for celecoxib and Medulloblastoma
Article | Year |
---|---|
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemothera | 2013 |
Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Apoptosis; Celecoxib; Cell Line, Tumor; Cerebellar Neoplasms; | 2014 |
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; beta Catenin; Brain Neoplasms; Camptothecin; Cele | 2015 |
Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Apoptosis; Celecoxib; Cell Division; Cell Line, Tumor; Cerebel | 2010 |
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.
Topics: Adult; Animals; Antiviral Agents; Brain Neoplasms; Celecoxib; Cell Line, Tumor; Child; Child, Presch | 2011 |
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherap | 2012 |